or Try an Advanced Search...

    Technical Analysis for QNRX - Quoin Pharmaceuticals, Ltd.

    Grade Last Price % Change Price Change
    D 0.76 1.51% 0.01
    QNRX closed up 1.51 percent on Friday, November 1, 2024, on 4 percent of normal volume.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Up Down
    Historical QNRX trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion 1.51%
    Wide Bands Range Expansion -6.38%
    Shooting Star Candlestick Bearish -13.85%
    Wide Bands Range Expansion -13.85%
    Wide Bands Range Expansion -13.72%
    1,2,3 Pullback Bullish Bullish Swing Setup -6.14%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.14%
    Calm After Storm Range Contraction -6.14%
    NR7 Range Contraction -6.14%
    Older End-of-Day Signals for QNRX ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 21 hours ago
    Possible NR7 about 21 hours ago
    60 Minute Opening Range Breakdown 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    QNRX Chart by TradingView
    Basic chart:

    Profile

    Founded in 2018 as Quoin Pharmaceuticals Inc. by Michael Myers Ph.D. and Denise Carter, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Pharmaceutical Therapeutic Products Genodermatoses Epidermolysis Bullosa Netherton Syndrome Rare And Orphan Diseases

    Is QNRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
    Oct 22 Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome
    Oct 17 Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Sep 9 Quoin Pharmaceuticals announces insider share purchases
    Sep 9 Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO
    Aug 22 QNRX: Assessing QRX003 For Multiple Conditions; Opening International Netherton Syndrome Clinical Sites
    Aug 8 Quoin Pharmaceuticals reports Q2 results
    Aug 8 Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results
    Aug 6 Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
    Aug 1 Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024
    See more QNRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.18
    52 Week Low 0.4772
    Average Volume 3,299,028
    200-Day Moving Average 1.09
    50-Day Moving Average 0.64
    20-Day Moving Average 0.70
    10-Day Moving Average 0.81
    Average True Range 0.13
    RSI (14) 54.34
    ADX 55.41
    +DI 49.19
    -DI 11.93
    Chandelier Exit (Long, 3 ATRs) 1.19
    Chandelier Exit (Short, 3 ATRs) 0.86
    Upper Bollinger Bands 0.99
    Lower Bollinger Band 0.40
    Percent B (%b) 0.6
    BandWidth 84.66
    MACD Line 0.06
    MACD Signal Line 0.06
    MACD Histogram 0.0034
    Fundamentals Value
    Market Cap 748.71 Thousand
    Num Shares 987 Thousand
    EPS 1.38
    Price-to-Earnings (P/E) Ratio 0.55
    Price-to-Sales 0.00
    Price-to-Book 0.45
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.87
    Resistance 3 (R3) 0.87 0.83 0.85
    Resistance 2 (R2) 0.83 0.80 0.83 0.84
    Resistance 1 (R1) 0.79 0.79 0.81 0.79 0.84
    Pivot Point 0.76 0.76 0.77 0.76 0.76
    Support 1 (S1) 0.72 0.73 0.74 0.72 0.68
    Support 2 (S2) 0.69 0.71 0.69 0.67
    Support 3 (S3) 0.65 0.69 0.67
    Support 4 (S4) 0.65